Adva Biotechnology × Autolomous
Company overview
Adva Biotechnology develops automated, adaptive cell processing platforms, while Autolomous provides software and data solutions to enable intelligent cell therapy manufacturing.
What’s the news
The companies are announcing a strategic partnership focused on advancing automated, software-driven, and intelligent manufacturing workflows for cell therapies. Details to be announced ahead of Advanced Therapies Week 2026.
Key topics
Cell therapy automation; AI and machine learning in biomanufacturing; adaptive manufacturing platforms; digital control systems; smart and flexible cell processing; manufacturing innovation partnerships
BBG Advanced Therapies (BioBridge Global)
Company overview
BBG Advanced Therapies delivers integrated solutions spanning starting material collection, testing, and manufacturing to support advanced therapy development globally.
What’s the news
The company is showcasing a mobile, ECO-free manufacturing center supported by newly generated data, following its initial public debut in 2025.
Key topics
Mobile manufacturing; ECO-free cell therapy production; flexible and decentralized manufacturing; modular infrastructure; innovation in CGT delivery models
BioLife Solutions
Company overview
BioLife Solutions develops biopreservation and cell processing technologies that support cell and gene therapies from development through commercial delivery, helping preserve cell viability and potency at scale.
What’s the news
The company has launched the Aby J. Mathew Center for Biopreservation Excellence, a global hub advancing cryopreservation science and standardized preservation methods as CGTs transition to commercialization.
Key topics
Cell and gene therapy commercialization; cryopreservation and biopreservation science; cold chain and logistics; process standardization; next-generation preservation technologies; CGT scalability and access
Cellares
Company overview
Cellares is an Integrated Development and Manufacturing Organization (IDMO) applying Industry 4.0 principles to automate and industrialize cell therapy manufacturing.
What’s the news
The company is advancing an automated, digital manufacturing platform designed to replace manual, fragmented workflows with standardized, scalable production for global patient demand.
Key topics
Cell therapy manufacturing at scale; Industry 4.0 biomanufacturing; automation and digital manufacturing; IDMO models; cost reduction; commercial-scale production; global access
Dark Horse Consulting
Company overview
Dark Horse Consulting is a specialist advisory firm focused exclusively on cell and gene therapy, supporting companies, technology providers, and investors across development and commercialization.
What’s the news
Announcements and updates are expected ahead of Advanced Therapies Week 2026.
Key topics
CGT development strategy; manufacturing and process development; regulatory and quality systems; analytical development; program management; CGT advisory services
Kincell Bio
Company overview
Kincell Bio is a CDMO focused on CMC development and GMP manufacturing for immune cell therapies, supporting programs from early clinical development through commercial launch.
What’s the news
Kincell Bio has appointed industry veteran Larry Pitcher as CEO following a year of strong client growth and late-stage program advancement, with former CEO Mark Bamforth OBE moving to Executive Chair.
Key topics
Cell therapy manufacturing scale-up; CMC development; late-stage and commercial GMP; CAR-T, CAR-NK, TCRs and Tregs; CDMO readiness; leadership and operational expansion
LumaCyte
Company overview
LumaCyte delivers predictive, label-free cell analytics for advanced therapy biomanufacturing through its cellular Process Analytical Technology (PAT) platform.
What’s the news
LumaCyte is redefining cellular Process Analytical Technology (PAT) with Radiance®.
Key topics
Cellular PAT; predictive analytics; label-free cell analytics; CGT manufacturing scale-up; GMP-ready QC analytics; real-time process monitoring; potency prediction; in-process control strategies; donor variability management; CAR-T and stem cell manufacturing; tech transfer acceleration; ISO-aligned analytics; regulatory-ready manufacturing controls
Nucleus Biologics
Company overview
Nucleus Biologics provides cell culture media and services to support current and next-generation advanced therapy programs.
What’s the news
Further information on new capabilities and developments will be shared ahead of Advanced Therapies Week 2026.
Key topics
Cell culture media and reagents; cell expansion technologies; process efficiency; manufacturing timelines and scalability; enabling tools for advanced therapies
RoslinCT
Company overview
RoslinCT is a cell and gene therapy CDMO with origins at the Roslin Institute, supporting development and commercialization across autologous and allogeneic therapies.
What’s the news
Additional updates will be announced ahead of Advanced Therapies Week 2026.
Key topics
Cell and gene therapy manufacturing; pluripotent stem cells; CRISPR-edited cell therapies; cGMP scale-up; regulatory-ready production; commercialization
Uniphar
Company overview
Uniphar is a global partner to pharma, biotech and medtech companies, delivering integrated services across Development, Clinical, Access, Medical, Commercial, Distribution and Global Sourcing.
What’s the news
Uniphar is accelerating its U.S. expansion through the integration and rebranding of RRD Biopharma Development, Uniphar Clinical, Diligent Health Solutions and BESTMSLs under a single Uniphar identity.
Key topics
Integrated pharma services; clinical development services; medical affairs and medical information; market access and pricing; field medical and MSL deployment; commercialization support; global distribution and supply chain; rare disease access; lifecycle management; end-to-end product lifecycle integration
Honorable mentions:
)